China Pharma IP Summit (CPIPS) 2019

Fish’s Teresa Lavoie, a Principal in our Twin Cities office, will be a panelist on the “IP Considerations & Strategies for Pharma Companies When Entering the U.S. Market” panel during the 2019 China Pharma IP Summit (CPIPS) on October 23-25 in Shanghai, China.

CPIPS is the largest IP event in China focused on the pharma and biotech industry. The conference will cover a wide range of topics, including the latest developments in Chinese patent law, uncertainties and challenges under Brexit, U.S. biosimilar patent litigation strategies and trends, and how to build a successful licensing program. Panel details are below.

Thursday, October 24
11:45AM - 12:30PM
Panel Discussion: IP Considerations & Strategies for Pharma Companies When Entering the U.S. Market

Topics of discussion include:
• Developing Your IP Portfolio to Maximize Value
• U.S. Specific Issues - Don’t let them trip you up!
• Ownership and Inventorship
• CROs, Foreign filing licenses, and the On-Sale Bar
• Partnering and Due Diligence - Best Practices

Moderator: Wu Li, Partner, Anjie Law Firm

• Teresa Lavoie, Principal, Fish & Richardson
• Caihui Li, Senior IP Director, 3SBio Group
• Andy Zhang, Senior Corporate Counsel, Intellectual Property, Sunovion Pharmaceutical
• Bharati Nadkarni, Vice President Portfolio Planning and IP Litigation, Sun Pharmaceutical

Click here to learn more.

China Pharma IP Summit 2019
October 23-25, 2019
PRIMUS Hotel Shanghai Hongqiao
Lane 1588, Zhuguang Road, Xujing Town
Qingpu District, Shanghai, China